M&A Deal Summary |
|
---|---|
Date | 2023-04-28 |
Target | CW Advisors |
Sector | Financial Services |
Buyer(s) | Audax Private Equity |
Deal Type | Recapitalization |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 1999 |
PE ASSETS | 19.0B USD |
Size | Mega |
Type | Sector Agnostic |
Audax Private Equity is a private equity firm focused on acquiring control positions in a variety of mid to large North American headquartered companies. The Firm segments its activities into lower middle-market and larger scale investing. Within its larger group, Audax targets profitable businesses valued up to $800 million and within its lower middle-market group, the Firm seeks companies valued up to $125 million. Sectors of interest include business services, consumer products/services, financial services, healthcare services, industrial services, software, and technology. Audax has a special interest in businesses that can benefit from a buy and build investment strategy for growth. Audax Private Equity was formed in 1999 and is based in Boston, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 163 of 167 |
Sector (Financial Services) | 4 of 4 |
Type (Recapitalization) | 15 of 15 |
State (Massachusetts) | 13 of 13 |
Country (United States) | 155 of 158 |
Year (2023) | 4 of 6 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2023-04-18 |
Pyramid Laboratories
Costa Mesa, California, United States Pyramid Laboratories is a drug-product contract development and manufacturing organization (CDMO) that provides formulation development, analytical and stability testing, and aseptic fill-finish manufacturing services focused on large-molecule therapeutics. Pyramid Laboratories was founded in 1988 and is based in Costa Mesa, California. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2023-07-06 |
CorEvitas
Waltham, Massachusetts, United States CorEvitas provides real-world evidence through syndicated registry data and analysis services, helping biopharmaceutical companies demonstrate the value of their products to clinicians, patients, payers, and regulators. Corona operates six major autoimmune registries across the US, Canada, and Japan, collecting data from over 500 participating investigator sites. CorEvitas was founded in 2001 and is based in Waltham, Massachusetts. |
Sell | $913M |